Anesthesia of seven sevoflurane combined with remifentanil for laparoscopic cholecystectomy
10.3969/j.issn.1005-1678.2017.06.103
- VernacularTitle:七氟烷复合瑞芬太尼用于腹腔镜胆囊切除术的麻醉
- Author:
Chongfa ZHAO
;
Yanhui GUO
;
Jie GAO
;
Xiaowei SHI
- Keywords:
sevoflurane;
remifentanil;
laparoscopic cholecystectomy;
anesthetic effect
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(6):276-277
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the clinical effect of sevoflurane combined with remifentanil in laparoscopic cholecystectomy (LC).Methods50 cases of laparoscopic cholecystectomy in Tianjin Haihe Hospital from February 2015 to September 2016 were selected as the research object, and randomly divided into the control group and the experimental group, each group had a total of 25 cases.The patients in control group were treated with continuous intravenous infusion of propofol.The experimental group received sevoflurane.Patients in the experimental group and the control group were given remifentanil after surgery.Compared with the experimental group and control group of patients with the degree of recovery and related Linchuan indicators.ResultsAfter the corresponding anesthesia, the control group of patients with recovery time was (13.4±3.1) minutes, the score was (4.1±1.2) points, extubation time was (14.6±3.7) minutes.However, the extubation time and recovery time of the control group were significantly longer than those of the experimental group, and the recovery score was lower than that of the experimental group, with statistical difference (P<0.05).There was no obvious adverse reaction in the experimental group and the control group, and there was no significant difference in the changes of cardiovascular factors.ConclusionSevoflurane combined with remifentanil for laparoscopic cholecystectomy can improve the anesthetic effect to a great extent, stable operation and postoperative patients with cardiovascular function, recovery time is short, the clinical significance of only one step promotion and application.
